Select Page

Anti-Human CD52 (Alemtuzumab) – APC – 50 µg

ST0017-1
50 µg

$227.85

DATA SHEET

TargetCD52
ApplicationFA, FC, IHC FF, IHC FFPE
ClonalityMonoclonal
ConjugateAllophycocyanin (APC)
IsotypeHuman IgG1κ
ImmunogenHuman lymphocytes.
Species ReactivityHuman, Cynomolgus Monkey, Rhesus Monkey
FormulationThis Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Research AreaCancer, Immunology
Description/BackgroundClone Campath-1H is a monoclonal antibody that specifically binds to CD52, a protein present on the surface of mature lymphocytes. However, this protein is not present on the stem cells that generated these lymphocytes. Alemtuzumab is targets and destroys mature lymphocytes containing CD-52, and is used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. Anti-Human CD52 (Alemtuzumab) utilizes the same variable regions from the therapeutic antibody Alemtuzumab making it ideal for research projects.
Storage TemperatureThis Allophycocyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze.
ProtocolsFA, FC, IHC FF, IHC FFPE
Clone NumberCampath-1H
Concentration0.2 mg/ml
Regulatory StatementFor Research Use Only. Not for use in diagnostic procedures.
ST0017-1
50 µg

$227.85

SIGN UP